Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6FNT

Ergothioneine-biosynthetic methyltransferase EgtD in complex with pyrrolidinohistidine

Summary for 6FNT
Entry DOI10.2210/pdb6fnt/pdb
DescriptorHistidine N-alpha-methyltransferase, Pyrrolidinohistidine (3 entities in total)
Functional Keywordsergothioneine, methyltransferase, inhibitor complex, transferase
Biological sourceMycobacterium smegmatis
Total number of polymer chains2
Total formula weight70987.91
Authors
Vit, A.,Blankenfeldt, W.,Seebeck, F.P. (deposition date: 2018-02-05, release date: 2018-06-13, Last modification date: 2024-01-17)
Primary citationMisson, L.,Burn, R.,Vit, A.,Hildesheim, J.,Beliaeva, M.A.,Blankenfeldt, W.,Seebeck, F.P.
Inhibition and Regulation of the Ergothioneine Biosynthetic Methyltransferase EgtD.
ACS Chem. Biol., 13:1333-1342, 2018
Cited by
PubMed Abstract: Ergothioneine is an emerging factor in cellular redox homeostasis in bacteria, fungi, plants, and animals. Reports that ergothioneine biosynthesis may be important for the pathogenicity of bacteria and fungi raise the question as to how this pathway is regulated and whether the corresponding enzymes may be therapeutic targets. The first step in ergothioneine biosynthesis is catalyzed by the methyltransferase EgtD that converts histidine into N-α-trimethylhistidine. This report examines the kinetic, thermodynamic and structural basis for substrate, product, and inhibitor binding by EgtD from Mycobacterium smegmatis. This study reveals an unprecedented substrate binding mechanism and a fine-tuned affinity landscape as determinants for product specificity and product inhibition. Both properties are evolved features that optimize the function of EgtD in the context of cellular ergothioneine production. On the basis of these findings, we developed a series of simple histidine derivatives that inhibit methyltransferase activity at low micromolar concentrations. Crystal structures of inhibited complexes validate this structure- and mechanism-based design strategy.
PubMed: 29658702
DOI: 10.1021/acschembio.8b00127
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

238895

PDB entries from 2025-07-16

PDB statisticsPDBj update infoContact PDBjnumon